Breaking News Instant updates and real-time market news.

COP

ConocoPhillips

$71.95

0.5 (0.70%)

, BP

BP

$45.32

-0.03 (-0.07%)

15:48
07/13/18
07/13
15:48
07/13/18
15:48

U.S., allies weigh possible oil-reserve release, WSJ reports

As oil prices rise, U.S. President Donald Trump has implored Saudi Arabia and OPEC to pump more oil, the Wall Street Journal reports. If that doesn't help lower prices, U.S. and Western officials are considering another move: an emergency release of stockpiled oil across the globe, the report says, citing people familiar with the matter. The Trump administration is actively discussing whether to dip into the country's emergency oil stocks, the report says. The talks are part of a broader effort to ensure oil markets remain well supplied amid production disruptions around the world, as well as rising global demand, the report notes. Any draw down of the Strategic Petroleum Reserve is not imminent, and certain Trump advisers are strongly against the notion, the report says, citing people familiar with the matter. Publicly traded companies in the space include BP (BP), Chevron (CVX), ConocoPhillips (COP), Exxon Mobil (XOM), Royal Dutch Shell (RDS.A) and Total (TOT). Reference Link

COP

ConocoPhillips

$71.95

0.5 (0.70%)

BP

BP

$45.32

-0.03 (-0.07%)

RDS.A

Royal Dutch Shell

$69.92

0.46 (0.66%)

CVX

Chevron

$123.98

-0.26 (-0.21%)

XOM

Exxon Mobil

$83.32

0.65 (0.79%)

TOT

Total

$62.34

0.06 (0.10%)

  • 26

    Jul

  • 27

    Jul

COP ConocoPhillips
$71.95

0.5 (0.70%)

06/08/18
06/08/18
INITIATION

On The Fly: Top five analyst initiations
Catch up on today's top five analyst initiations with this list compiled by The Fly: 1. Pfizer (PFE) and Eli Lilly (LLY) were initiated with an Overweight at Cantor Fitzgerald. 2. LivaNova (LIVN) initiated with a Buy at Stifel. 3. Occidental Petroleum (OXY) and Chevron (CVX) were initiated with a Buy at Mizuho while ConocoPhillips (COP) and Exxon Mobil (XOM) were initiated with a Neutral. 4. LeMaitre (LMAT) resumed with a Buy at Roth Capital. 5. Savara (SVRA) initiated with an Outperform, sees 300% upside, says Evercore ISI. This list is just a portion of The Fly's analyst coverage. To see The Fly's full Street Research coverage, click here.
06/11/18
BMOC
06/11/18
INITIATION
Target $78
BMOC
Outperform
ConocoPhillips initiated with an Outperform at BMO Capital
BMO Capital analyst Phillip Jungwirth initiated ConocoPhillips with an Outperform rating and a price target of $78. The analyst expects the company's "Brent-levered, low-capital-intensive portfolio" to generate free cash flows that are 20%-30% above the management' payout target. Jungwirth also notes ConocoPhillips' "core shale position, conventional project start-up in the near term, and a stable LNG-oil sands production driving output growth". The analyst models $21B of excess free cash flows through FY22 or 26% of its current market cap after including the FY18 dividend payout and debt repayment.
07/11/18
LEHM
07/11/18
DOWNGRADE
Target $66
LEHM
Underweight
Barclays downgrades Hess to Underweight on 'steepest' group premium
Barclays analyst Paul Cheng downgraded Hess Corp. (HES) to Underweight from Equal Weight while raising his price target for the shares to $66 from $55. The analyst says his analysis indicates Hess trades at the "steepest premium" in the group. His Guyana estimate would need to move 75%-100% higher for Hess to trade in-line with large-cap Exploration and Production companies. Cheng replaced Cenovus Energy (CVE) with ConocoPhillips (COP) as his top pick following the stock's strong share performance. He also double upgraded Petrobras (PBR) Overweight from Underweight, upgraded Husky Energy (HUSKF) to Overweight and Imperial Oil (IMO) to Equal Weight. The analyst thinks Hess and Exxon Mobil (XOM) offer the least value over the next 12 months.
07/12/18
MSCO
07/12/18
INITIATION
Target $82
MSCO
Overweight
ConocoPhillips initiated with an Overweight at Morgan Stanley
Morgan Stanley analysts Devin McDermott and Drew Venker added coverage of 12 large-cap and diversified E&Ps, identifying ConocoPhillips (COP), Occidental Petroleum (OXY) and Continental Resources (CLR) as their top picks. The analysts set an $82 price target on Overweight-rated ConocoPhillips.
BP BP
$45.32

-0.03 (-0.07%)

07/09/18
RBCM
07/09/18
UPGRADE
RBCM
Top Pick
BP upgraded to Top Pick from Outperform at RBC Capital
07/05/18
RBCM
07/05/18
UPGRADE
Target $10
RBCM
Outperform
Kosmos upgraded to Outperform at RBC Capital on oil outlook, Tortue development
As reported earlier, RBC Capital analyst Al Stanton upgraded Kosmos (KOS) to Outperform from Sector Perform and raised his price target to $10 from $7. The analyst cites his more positive outlook for higher oil price as well as more upbeat BP (BP) commentary on Tortue gas development offshore Mauritania/Senegal. Stanton estimates the company's production growth reaching 50% in FY18, with higher realisations and oil prices in 2019 leading to another 20% increase in output.
07/09/18
RBCM
07/09/18
UPGRADE
RBCM
Top Pick
BP upgraded to Top Pick from Outperform at RBC Capital
RBC Capital analyst Biraj Borkhataria upgraded BP to Top Pick from Outperform with a price target of GBP 675, saying the company's visibility for volume growth will lead to higher cash flows from operations. The analyst adds that BP has "one of the stronger growth profiles from now to 2020 among the majors" with further growth options beyond, while its liability payments from the Macondo disaster are diminishing as claims are reduced. Borkhataria also sees BP benefiting from wider crude spreads.
07/09/18
07/09/18
UPGRADE

On The Fly: Top five analyst upgrades
Catch up on today's top five analyst upgrades with this list compiled by The Fly: 1. FireEye (FEYE) upgraded to Overweight from Neutral at Piper Jaffray with analyst Andrew Nowinski saying a recent round of channel checks showed a "significant improvement" in demand trends for the company. 2. BP (BP) upgraded to Top Pick from Outperform at RBC Capital with analyst Biraj Borkhataria saying the company's visibility for volume growth will lead to higher cash flows from operations. 3. Capital One (COF) upgraded to Outperform from Perform at Oppenheimer with analyst Ben Chittenden saying the delinquency formation is improving and Q2 expectations seem too low to him. 4. Dunkin' Brands (DNKN) upgraded to Neutral from Underperform at Longbow with analyst Alton Stump saying his conversations with U.S. franchisees lead him to believe the company's Q2 same-store sales rose 0.5-1.0%, which would be in-line with the consensus view and slightly better than his prior forecast for them to have been flat with last year. 5. Baidu (BIDU) upgraded to Outperform from Neutral at Credit Suisse and to Overweight from Sector Weight at KeyBanc. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
RDS.A Royal Dutch Shell
$69.92

0.46 (0.66%)

04/11/18
DBAB
04/11/18
NO CHANGE
DBAB
Deutsche upgrades Eni to Buy, downgrades Total to Hold
Deutsche Bank analyst Lucas Herrmann coupled an upgrade of Eni SpA (E) to Buy from Hold with a downgrade of Total (TOT) to Hold from Buy. The analyst sees improving fundamentals and free cash flow yield for Eni. He raised his price target for the shares to EUR 16.50 from EUR 15.50. Herrmann moved to a Hold rating on Total following the recent "strong relative performance" of the shares. His price target for the stock of EUR 52 remains unchanged. The analyst calls BP (BP) and Royal Dutch Shell (RDS.A) his most preferred names in European Integrated Oil.
06/05/18
SOCG
06/05/18
DOWNGRADE
SOCG
Hold
Royal Dutch Shell downgraded to Hold from Buy at Societe Generale
07/06/18
DZBN
07/06/18
UPGRADE
DZBN
Buy
Royal Dutch Shell upgraded to Buy from Hold at DZ Bank
DZ Bank analyst Werner Eisenmann upgraded Royal Dutch Shell to Buy.
07/06/18
07/06/18
UPGRADE

On The Fly: Top five analyst upgrades
Catch up on today's top five analyst upgrades with this list compiled by The Fly: 1. Biogen (BIIB) upgraded to Buy from Neutral at Citi with analyst Robyn Karnauskas citing the company's announcement of positive results from an 18-month clinical trial for BAN2401, a drug to treat Alzheimer's. 2. Starbucks (SBUX) upgraded to Hold from Sell at DZ Bank. 3. Royal Dutch Shell (RDS.A) upgraded to Buy from Hold at DZ Bank. 4. Millicom (MIICF) upgraded to Buy from Neutral at BofA/Merrill. 5. ManTech (MANT) upgraded to Buy from Hold at SunTrust with analyst Tobey Sommer citing the company's "superior positioning to further accelerate market share gains and capitalize on federal budget increases". This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
CVX Chevron
$123.98

-0.26 (-0.21%)

06/18/18
RAJA
06/18/18
UPGRADE
RAJA
Outperform
Chevron upgraded to Outperform from Market Perform at Raymond James
06/18/18
06/18/18
UPGRADE
Target $140

Outperform
Chevron upgraded to Outperform on oil price leverage, buybacks at Raymond James
As previously reported, Raymond James upgraded Chevron to Outperform from Market Perform and established a $140 price target. Analyst Pavel Molchanov said Chevron offers relatively more leverage than most peers to higher oil prices, which should reach cyclical highs over the next 6 to 12 months, while low WTI exposure maximizes earnings and free cash flow generation. Molchanov sees free cash flow above 6% driving a resumption in buybacks and notes shares are down 1% year-to-date, versus the IXE gain of 3%.
06/18/18
06/18/18
UPGRADE

On The Fly: Top five analyst upgrades
Catch up on today's top five analyst upgrades with this list compiled by The Fly: 1. Francesca's (FRAN) upgraded to Buy from Neutral at B. Riley FBR with analyst Susan Anderson saying she has increased confidence in the company's turnaround following meetings with management. 2. Chevron (CVX) upgraded to Outperform from Market Perform at Raymond James with analyst Pavel Molchanov saying Chevron offers relatively more leverage than most peers to higher oil prices, which should reach cyclical highs over the next 6 to 12 months, while low WTI exposure maximizes earnings and free cash flow generation. 3. Trovagene (TROV) upgraded to Buy from Hold at Maxim with analyst Jason McCarthy citing the positive news from the company's lead drug candidate PCM-075 as well as its completion of a capital raise. 4. RBS (RBS) upgraded to Buy from Hold at Investec. 5. Teva (TEVA) upgraded to Market Perform from Underperform at Wells Fargo with analyst David Maris citing a "positive meeting" with Teva's CEO Kundefinedre Schultz and CFO Mike McClellan in Israel. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
07/03/18
MACQ
07/03/18
DOWNGRADE
MACQ
Neutral
Chevron downgraded to Neutral from Outperform at Macquarie
Macquarie downgraded Chevron to Neutral from Outperform and cut its price target to $125 price target from $140.
XOM Exxon Mobil
$83.32

0.65 (0.79%)

05/30/18
05/30/18
UPGRADE

On The Fly: Top five analyst upgrades
Catch up on today's top five analyst upgrades with this list compiled by The Fly: 1. Exxon Mobil (XOM) upgraded to Outperform from Sector Perform at RBC Capital with analyst Biraj Borkhataria saying the stock trades at 8.4-times expected enterprise value to debt-adjusted cash flow vs. 7.1-times for other "super majors" in the industry, forecasting that premium to shrink by 2023 given Exxon Mobil's "superior cash flow growth and debt reduction potential." 2. HP Inc. (HPQ) upgraded to Buy from Hold at Maxim with analyst Nehal Chokshi saying the company's base business is priced "attractively" as the latest quarter places it on track for low-single digit growth. 3. Meredith (MDP) upgraded to Outperform from Neutral at Credit Suisse with analyst Jason Bazinet saying he attributes the weakness in the shares over the past six months to the company's elevated debt levels and deteriorating print ad trends. 4. Allegheny Technologies (ATI) upgraded to Neutral from Sell at Goldman Sachs with analyst Matthew Korn citing the company's "consistency" of growing within a technologically challenging market as well as its fair valuation, while adding that there is some upside to his forecasts based on its operational strength. 5. G-III Apparel (GIII) upgraded to Outperform from Market Perform at Cowen with analyst John Kernan saying he believes free cash flow will improve with the expansion of Donna Karan profitability and as earnings headwinds diminish. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
06/08/18
MZHO
06/08/18
INITIATION
Target $81
MZHO
Neutral
Exxon Mobil initiated with a Neutral at Mizuho
Mizuho analyst Paul Sankey started Exxon Mobil (XOM) with a Neutral rating and $81 price target. The analyst doesn't see "real growth" from the company until 2020 and prefers shares of Chevron (CVX).
TOT Total
$62.34

0.06 (0.10%)

05/16/18
UBSW
05/16/18
DOWNGRADE
UBSW
Neutral
Total downgraded to Neutral from Buy at UBS
05/21/18
SANT
05/21/18
DOWNGRADE
SANT
Total downgraded to Hold from Buy at Santander
06/11/18
JEFF
06/11/18
UPGRADE
JEFF
Buy
Total upgraded to Buy from Hold at Jefferies
Jefferies analyst Jason Gammel upgraded Total to Buy and raised his price target for the shares to EUR 62 from EUR 51. A "robust" free cash flow yield averaging 9.2% and annual production growth of 7% to 2020 are attractive in a rising oil price environment, Gammel tells investors in a research note.
07/05/18
07/05/18
DOWNGRADE

On The Fly: Top five analyst downgrades
Catch up on today's top five analyst downgrades with this list compiled by The Fly: 1. Munich Re (MURGY) downgraded to Neutral from Overweight at JPMorgan. 2. Domino's Pizza Enterprises (DPZUF) downgraded to Sell from Neutral at Citi. 3. NextEra Energy downgraded to Market Perform from Outperform at Raymond James with analyst Pavel Molchanov saying NextEra's 3.6% yield is the lowest among yieldcos and he recommends waiting for a better entry point. 4. Clean Energy (CLNE) downgraded to Underperform from Market Perform at Raymond James with analyst Pavel Molchanov saying he believes shares reflect "excessive euphoria" over the partnership with Total (TOT). 5. Fresenius Medical (FMS) downgraded to Neutral from Outperform at Credit Suisse. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.

TODAY'S FREE FLY STORIES

SRLP

Sprague Resources

$19.31

-0.24 (-1.23%)

06:05
01/23/19
01/23
06:05
01/23/19
06:05
Hot Stocks
Sprague Resources lowers FY18 adjusted EBITDA view to below $110M-$120M »

Sprague CEO David Glendon…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

TEL

TE Connectivity

$79.46

-1.78 (-2.19%)

06:05
01/23/19
01/23
06:05
01/23/19
06:05
Earnings
TE Connectivity reports Q1 adj. EPS $1.29, consensus $1.28 »

Reports Q1 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Jan

  • 25

    Feb

  • 28

    May

TEVA

Teva

$18.75

-0.06 (-0.32%)

06:04
01/23/19
01/23
06:04
01/23/19
06:04
Upgrade
Teva rating change  »

Teva upgraded to Neutral…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 13

    Feb

UNTY

Unity Bancorp

$19.85

0.065 (0.33%)

06:03
01/23/19
01/23
06:03
01/23/19
06:03
Earnings
Breaking Earnings news story on Unity Bancorp »

Unity Bancorp reports Q4…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CBPX

Continental Building

$25.55

-0.32 (-1.24%)

06:03
01/23/19
01/23
06:03
01/23/19
06:03
Downgrade
Continental Building rating change  »

Continental Building…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ATHX

Athersys

$1.40

-0.03 (-2.10%)

06:02
01/23/19
01/23
06:02
01/23/19
06:02
Hot Stocks
Athersys reports 'positive' results from study of MultiStem cell therapy »

Athersys announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

TOL

Toll Brothers

$34.45

-0.5 (-1.43%)

05:57
01/23/19
01/23
05:57
01/23/19
05:57
Downgrade
Toll Brothers rating change  »

Toll Brothers downgraded…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

KBR

KBR

$17.13

-0.48 (-2.73%)

05:56
01/23/19
01/23
05:56
01/23/19
05:56
Hot Stocks
KBR secures contract for K-SAAT »

KBR announced that it has…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

INFY

Infosys

$10.54

-0.14 (-1.31%)

05:54
01/23/19
01/23
05:54
01/23/19
05:54
Hot Stocks
Infosys enters partnership with HPE GreenLake »

Infosys announced that it…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Jan

WY

Weyerhaeuser

$24.55

-0.54 (-2.15%)

05:54
01/23/19
01/23
05:54
01/23/19
05:54
Initiation
Weyerhaeuser initiated  »

Weyerhaeuser initiated…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 01

    Feb

SNE

Sony

$48.46

-1.705 (-3.40%)

05:54
01/23/19
01/23
05:54
01/23/19
05:54
Hot Stocks
Sony announces formation of Sony Home Entertainment & Sound Products »

Sony Visual Products…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

DHI

D.R. Horton

$36.43

-0.74 (-1.99%)

, LEN

Lennar

$43.48

-0.63 (-1.43%)

05:54
01/23/19
01/23
05:54
01/23/19
05:54
Upgrade
D.R. Horton, Lennar rating change  »

D.R. Horton upgraded to…

DHI

D.R. Horton

$36.43

-0.74 (-1.99%)

LEN

Lennar

$43.48

-0.63 (-1.43%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Jan

  • 25

    Jan

ZNGA

Zynga

$4.33

0.065 (1.53%)

05:53
01/23/19
01/23
05:53
01/23/19
05:53
Periodicals
Zynga founder raising up to $700M for new investment fund, Axios reports »

Zynga founder Mark Pincus…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 06

    Feb

YELP

Yelp

$35.37

-0.895 (-2.47%)

05:51
01/23/19
01/23
05:51
01/23/19
05:51
Periodicals
SCOTUS won't hear lawsuit over defamatory Yelp reviews, The Verge reports »

The Supreme Court has…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Jan

HII

Huntington Ingalls

$196.46

-3.82 (-1.91%)

05:50
01/23/19
01/23
05:50
01/23/19
05:50
Downgrade
Huntington Ingalls rating change  »

Huntington Ingalls…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 14

    Feb

KCDMY

Kimberly-Clark de Mexico

$0.00

(0.00%)

05:49
01/23/19
01/23
05:49
01/23/19
05:49
Downgrade
Kimberly-Clark de Mexico rating change  »

Kimberly-Clark de Mexico…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

DDAIF

Daimler AG

$0.00

(0.00%)

05:47
01/23/19
01/23
05:47
01/23/19
05:47
Upgrade
Daimler AG rating change  »

Daimler AG upgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CEO

CNOOC

$161.22

-5.52 (-3.31%)

05:44
01/23/19
01/23
05:44
01/23/19
05:44
Hot Stocks
CNOOC announces 2019 business strategy, development plan »

CNOOC announced its…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

BHVN

Biohaven Pharmaceutical

$35.83

-1.04 (-2.82%)

, AZN

AstraZeneca

$36.27

-0.28 (-0.77%)

05:43
01/23/19
01/23
05:43
01/23/19
05:43
Hot Stocks
Biohaven allowed to proceed with BHV-3241 Phase 3 clinical trial »

Biohaven Pharmaceutical…

BHVN

Biohaven Pharmaceutical

$35.83

-1.04 (-2.82%)

AZN

AstraZeneca

$36.27

-0.28 (-0.77%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Feb

  • 20

    Feb

ASML

ASML

$159.39

-3.34 (-2.05%)

05:38
01/23/19
01/23
05:38
01/23/19
05:38
Hot Stocks
ASML, Nikon, Carl Zeiss sign agreement to settle all litigation »

Nikon, ASML Holding, and…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Jan

ASLN

Aslan Pharmaceuticals

$3.55

(0.00%)

05:36
01/23/19
01/23
05:36
01/23/19
05:36
Hot Stocks
Aslan says varlitinib pre-clinical data published online in Cancers »

Aslan Pharmaceuticals…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

LAMR

Lamar Advertising

$73.53

-0.59 (-0.80%)

05:35
01/23/19
01/23
05:35
01/23/19
05:35
Recommendations
Lamar Advertising analyst commentary  »

Lamar Advertising price…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Feb

  • 25

    Feb

ABBV

AbbVie

$88.70

-0.81 (-0.90%)

05:33
01/23/19
01/23
05:33
01/23/19
05:33
Initiation
AbbVie initiated  »

AbbVie assumed with a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Jan

  • 28

    Jan

  • 18

    May

PFE

Pfizer

$42.26

-0.26 (-0.61%)

05:31
01/23/19
01/23
05:31
01/23/19
05:31
Downgrade
Pfizer rating change  »

Pfizer downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Jan

  • 29

    Jan

  • 18

    May

XOM

Exxon Mobil

$71.89

-1.09 (-1.49%)

05:30
01/23/19
01/23
05:30
01/23/19
05:30
Hot Stocks
Exxon Mobil, REG enter joint research agreement with Clariant »

ExxonMobil and Renewable…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 01

    Feb

  • 10

    Feb

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.